Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.41 |
| ▸ | CES1 | P23141 | 10/20 | 0.39 |
| ▸ | CES2 | O00748 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16320977 | 0.88 | CES2 (0.35) | FAAHCES1CES2ALDH1A1 | |
| SCHEMBL16341255 | 0.82 | FAAH (0.39) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL16341021 | 0.79 | — | — | |
| SCHEMBL27492133 | 0.77 | FAAH (0.45) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2863276 | 0.77 | FAAH (0.45) | FAAHCES1CES2MEN1CYP1A2 | |
| Hydrogen Sulfide SCHEMBL28099748 | 0.75 | FAAH (0.43) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL11232114 | 0.73 | CES1 (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL27889313 | 0.72 | FAAH (0.53) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL29655327 | 0.71 | FAAH (0.54) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL29487300 | 0.71 | FAAH (0.54) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9775371-B2 | Decanoic acid derivatives and flavoring compositions | T. HASEGAWA CO., LTD. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20140377434-A1 | NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS | T. HASEGAWA CO., LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140377434-A1 | NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS | TAS2R5, FFAR3, FFAR1 | FAAH 283/4885CES1 590/4885CES2 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.